CN Patent

CN115141149A — 作为tyk2假激酶结构域抑制剂的杂环化合物及合成方法和用途

Assigned to Zhejiang Wenda Pharmaceutical Technology Co ltd · Expires 2022-10-04 · 4y expired

What this patent protects

本发明提供了作为TYK2假激酶(Pseudokinase,JH2)结构域抑制剂的杂环化合物及合成方法和用途。具体地，本发明提供了如式I所示的杂环化合物或其药学上可接受的盐，其中，各基团如文本中定义。本发明的杂环化合物具有优异的TYK2(JH2)选择抑制活性。

USPTO Abstract

本发明提供了作为TYK2假激酶(Pseudokinase,JH2)结构域抑制剂的杂环化合物及合成方法和用途。具体地，本发明提供了如式I所示的杂环化合物或其药学上可接受的盐，其中，各基团如文本中定义。本发明的杂环化合物具有优异的TYK2(JH2)选择抑制活性。

Drugs covered by this patent

Patent Metadata

Patent number
CN115141149A
Jurisdiction
CN
Classification
—
Expires
2022-10-04
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Wenda Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.